See your results below for :
Brixadi (Weekly) 1ML of 24MG/0.48ML
:
Syringe - 1
Brixadi (Weekly) Coupons & Prices
What is Brixadi (Weekly) ?
Brixadi (Weekly) is an extended-release injectable suspension of buprenorphine used for the treatment of moderate to severe opioid use disorder in patients who have initiated treatment with a transmucosal buprenorphine-containing product. Administered weekly, this medication is designed as part of a comprehensive treatment plan that includes counseling and psychosocial support, aiming to maintain patient compliance and reduce the risk of abuse, misuse, and addiction. It is intended for subcutaneous use under healthcare supervision.
Brixadi (Weekly)
Consumer Forms
Consumer Routes
Therapeutic Classes
- Nausea
- Headache
- Vomiting
- Constipation
- Dizziness
- Fatigue
- Injection site reactions
- Risk of respiratory depression
- Risk of opioid withdrawal syndrome
- Potential for abuse and dependence
- Use with caution in patients with severe hepatic impairment
- Avoid in patients with severe respiratory instability
- Interactions with benzodiazepines can result in sedation, respiratory depression, coma, and death
- Monitor for signs of injection site abscesses, cellulitis, and necrosis